Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HR18034 for analgesia after hemorrhoidectomy
ChiCTR2200065079Phase 2Not yet recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Nov 2022
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of liposomal ropivacaine in postoperative pain, sponsored by Third Xiangya Hospital, Central South University. Primary endpoints: NRS pain intensity scale and Pain Relief Score. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
liposomal ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2200065079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065079.